Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Explore how tracking spending trends helps you adjust your budget effectively. This guide shows practical steps to align expenses with goals without sacrificing essentials.
20,332 articlesRevolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
A top market analyst argues that heavily discounted altcoins may offer outsized upside as sentiment shifts, with Bitc...
SK Hynix is lining up a U.S. listing on Nasdaq, aiming to raise about $28 billion as memory chips ride AI demand and ...
A rural Georgia appliance plant combats a severe labor shortage by letting workers choose shifts through an app, easi...
A crypto-focused venture outfit scores a $1.2 billion fund rise, signaling a major shift toward AI and robotics along...
Jet fuel costs have dropped, yet airfares stay high as demand, hedges, and fees keep tickets elevated. Travelers face...
As UnitedHealth gears up for its July 16 results, traders focus on pricing power and rising cash flow as the main rea...
Synopsys stock faces near-term headwinds despite rising revenue, as margins and debt weigh on the long-term outlook. ...
A senior executive at Invesco disclosed a stock sale as the shares jumped about 63%. This article digs into what this...
Between Dec 31, 2025 and July 10, 2026, the Global X AI & Technology ETF rose about 24.74%, while Arista Networks cli...
Meta Platforms expands its lead in scalable ads and AI infrastructure, widening the gap to Palantir, whose high multi...
Pi Network surged 10% in a 24-hour window, reviving debate over a possible bottom. Analysts are weighing network pric...